Cargando…
Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19)()
The coronavirus 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has had enormous health, economic, and social consequences. The clinical spectrum of cutaneous manifestations observed in patients with COVID-19 is both heterogeneous and complex. To dat...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier España, S.L.U. on behalf of AEDV.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560260/ http://dx.doi.org/10.1016/j.adengl.2020.10.001 |
_version_ | 1783595046208012288 |
---|---|
author | Carrascosa, J.M. Morillas, V. Bielsa, I. Munera-Campos, M. |
author_facet | Carrascosa, J.M. Morillas, V. Bielsa, I. Munera-Campos, M. |
author_sort | Carrascosa, J.M. |
collection | PubMed |
description | The coronavirus 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has had enormous health, economic, and social consequences. The clinical spectrum of cutaneous manifestations observed in patients with COVID-19 is both heterogeneous and complex. To date, reports have identified 5 main categories: acral lesions, vesicular rashes, urticarial rashes, maculopapular rashes, and livedoid and necrotic lesions. However, these will probably be modified as new information comes to light. Cutaneous manifestations associated with COVID-19 probably reflect the activation of pathogenic pathways by the virus or a response to inflammatory processes, vascular or systemic complications, or even treatments. Familiarity with the cutaneous manifestations of COVID-19 may enable early diagnosis or help guide prognosis. |
format | Online Article Text |
id | pubmed-7560260 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Published by Elsevier España, S.L.U. on behalf of AEDV. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75602602020-10-16 Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19)() Carrascosa, J.M. Morillas, V. Bielsa, I. Munera-Campos, M. Actas Dermosifiliogr Novelties in Dermatology The coronavirus 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has had enormous health, economic, and social consequences. The clinical spectrum of cutaneous manifestations observed in patients with COVID-19 is both heterogeneous and complex. To date, reports have identified 5 main categories: acral lesions, vesicular rashes, urticarial rashes, maculopapular rashes, and livedoid and necrotic lesions. However, these will probably be modified as new information comes to light. Cutaneous manifestations associated with COVID-19 probably reflect the activation of pathogenic pathways by the virus or a response to inflammatory processes, vascular or systemic complications, or even treatments. Familiarity with the cutaneous manifestations of COVID-19 may enable early diagnosis or help guide prognosis. Published by Elsevier España, S.L.U. on behalf of AEDV. 2020-11 2020-10-15 /pmc/articles/PMC7560260/ http://dx.doi.org/10.1016/j.adengl.2020.10.001 Text en © 2020 Published by Elsevier España, S.L.U. on behalf of AEDV. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Novelties in Dermatology Carrascosa, J.M. Morillas, V. Bielsa, I. Munera-Campos, M. Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19)() |
title | Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19)() |
title_full | Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19)() |
title_fullStr | Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19)() |
title_full_unstemmed | Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19)() |
title_short | Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19)() |
title_sort | cutaneous manifestations in the context of sars-cov-2 infection (covid-19)() |
topic | Novelties in Dermatology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560260/ http://dx.doi.org/10.1016/j.adengl.2020.10.001 |
work_keys_str_mv | AT carrascosajm cutaneousmanifestationsinthecontextofsarscov2infectioncovid19 AT morillasv cutaneousmanifestationsinthecontextofsarscov2infectioncovid19 AT bielsai cutaneousmanifestationsinthecontextofsarscov2infectioncovid19 AT muneracamposm cutaneousmanifestationsinthecontextofsarscov2infectioncovid19 |